Yasir Bashir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yasir Bashir has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Ajay K. Manhar
Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur 784028, Assam, India
1 shared publicationAnggana Roy
Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam 784028
1 shared publication- Asad Ullah Khan
Antimicrobial Resistance Laboratory, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India
1 shared publication Bolin K. Konwar
Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur 784028, Assam, India
1 shared publicationBolin Kumar Konwar
Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam 784028, India
1 shared publication- Bolin Kumar Konwar
Dept. of Molecular Biology and Biotechnology, Tezpur University (Central), Napaam, India
1 shared publication
Latest Publications
- 8 February 2023
- Published by Springer Nature
- p. 519-528
Drug Repurposing in COVID-19 and Cancer: How Far Have We Come?
- 8 February 2023
- Published by Springer Nature
- p. 519-528
Drug Repurposing in COVID-19 and Cancer: How Far Have We Come?
- Open Access
- 1 July 2015
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Pharmacology
- Vol. 10 (3) , 697-702
Genome size determination of Eclipta alba and Aloe barbadensis
There is abundant genetic diversity of pharmacologically important plants around the globe and this pool of genetic variation serves as the base for selection as well as for plant improvement. The major cause of such genetic diversity is the variation in their genetic material, as called genome. In the present study, an attempt was made to determine the genome size of Eclipta alba and Aloe barbadensis by flow cytometry using Pisum sativum as a reference standard. The nuclear DNA was calculated as 8.7 pg for E. alba and 9.0 pg for A. barbadensis. The genome size of E. alba and A. barbadensis was estimated to be 4.27 x 109 bp and 4.42 x 109 bp, respectively. Information on genome size and DNA content of these two pharmacologically important plants would provide a useful tool for future molecular biological investigations.
- 1 July 2015
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Pharmacology
- Vol. 10 (3) , 697-702
Open AccessGenome size determination of Eclipta alba and Aloe barbadensis
There is abundant genetic diversity of pharmacologically important plants around the globe and this pool of genetic variation serves as the base for selection as well as for plant improvement. The major cause of such genetic diversity is the variation in their genetic material, as called genome. In the present study, an attempt was made to determine the genome size of Eclipta alba and Aloe barbadensis by flow cytometry using Pisum sativum as a reference standard. The nuclear DNA was calculated as 8.7 pg for E. alba and 9.0 pg for A. barbadensis. The genome size of E. alba and A. barbadensis was estimated to be 4.27 x 109 bp and 4.42 x 109 bp, respectively. Information on genome size and DNA content of these two pharmacologically important plants would provide a useful tool for future molecular biological investigations.
- 1 April 2015
- Published by Elsevier in Research in Veterinary Science
- Vol. 99, 149-156
In vitro evaluation of celluloytic Bacillus amyloliquefaciens AMS1 isolated from traditional fermented soybean (Churpi) as an animal probiotic
- 1 April 2015
- Published by Elsevier in Research in Veterinary Science
- Vol. 99, 149-156
In vitro evaluation of celluloytic Bacillus amyloliquefaciens AMS1 isolated from traditional fermented soybean (Churpi) as an animal probiotic
- Open Access
- 21 August 2014
- Published by Wiley in Chinese Journal of Biology
- Vol. 2014, 1-7
Metagenomics: An Application Based Perspective
Metagenomics deals with the isolation of genetic material directly recovered from environmental samples. Metagenomics as an approach has emerged over the past two decades to elucidate a host of microbial communities inhabiting a specific niche with the goal of understanding their genetic diversity, population structure, and ecological role played by them. A number of new and novel molecules with significant functionalities and applications have been identified through this approach. In fact, many investigators are engaged in this field to unlock the untapped genetic resources with funding from governments sector. The sustainable economic future of modern industrialized societies requires the development of novel molecules, enzymes, processes, products, and applications. Metagenomics can also be applied to solve practical challenges in the field of medicine, agriculture, sustainability, and ecology. Metagenomics promises to provide new molecules and novel enzymes with diverse functions and enhanced features compared to the enzymes from the culturable microorganisms. Besides the application of metagenomics for unlocking novel biocatalysts from nature, it also has found applications in fields as diverse as bioremediation, personalized medicine, xenobiotic metabolism, and so forth.
- 21 August 2014
- Published by Wiley in Chinese Journal of Biology
- Vol. 2014, 1-7
Open AccessMetagenomics: An Application Based Perspective
Metagenomics deals with the isolation of genetic material directly recovered from environmental samples. Metagenomics as an approach has emerged over the past two decades to elucidate a host of microbial communities inhabiting a specific niche with the goal of understanding their genetic diversity, population structure, and ecological role played by them. A number of new and novel molecules with significant functionalities and applications have been identified through this approach. In fact, many investigators are engaged in this field to unlock the untapped genetic resources with funding from governments sector. The sustainable economic future of modern industrialized societies requires the development of novel molecules, enzymes, processes, products, and applications. Metagenomics can also be applied to solve practical challenges in the field of medicine, agriculture, sustainability, and ecology. Metagenomics promises to provide new molecules and novel enzymes with diverse functions and enhanced features compared to the enzymes from the culturable microorganisms. Besides the application of metagenomics for unlocking novel biocatalysts from nature, it also has found applications in fields as diverse as bioremediation, personalized medicine, xenobiotic metabolism, and so forth.